


Ask a doctor about a prescription for OLANZAPINE NORMON 7.5 mg TABLETS
Package Leaflet: Information for the User
Olanzapine Normon 7.5 mg EFG Tablets
Read the package leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the Package Leaflet
Pharmacotherapeutic group: antipsychotic.
Olanzapine Normon is used to:
Do not takeOlanzapineNormon:
Consult your doctor or pharmacist before starting to take Olanzapine Normon.
If you have any of the following diseases, tell your doctor as soon as possible:
As a routine precaution, if you are over 65 years old, it is recommended that your doctor check your blood pressure.
Patients under 18 years old should not take Olanzapine Normon.
Use of Olanzapine Normon with other medicines
Only use other medicines at the same time as Olanzapine Normon if your doctor authorizes it. You may feel drowsy if you combine Olanzapine Normon with antidepressants or medicines for anxiety or sleep aids (tranquilizers). Inform your doctor especially if you are taking medication for Parkinson's disease.
You should inform your doctor if you are taking fluvoxamine (antidepressant) or ciprofloxacin (antibiotic), as it may be necessary to modify your dose of Olanzapine Normon.
Tell your doctor or pharmacist if you are using or have recently used or may need to use any other medication.
Taking Olanzapine Normon with food and drinks
The tablets can be taken with or without food, and you should swallow them whole with water.
You should not drink alcohol while taking Olanzapine Normon, as the combination with alcohol may cause drowsiness.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Pregnancy: Tell your doctor as soon as possible if you are pregnant or think you may be pregnant or plan to become pregnant. You should not take this medication during pregnancy unless your doctor recommends it.
Breastfeeding: You should not take this medication while breastfeeding, as small amounts of Olanzapine Normon may pass into breast milk.
Newborns of mothers who have used Olanzapine Normon in the last trimester of pregnancy may experience the following symptoms: tremors, muscle stiffness and/or weakness, drowsiness, agitation, breathing problems, and feeding problems. If your newborn experiences any of these symptoms, contact your doctor.
Driving and using machines
Olanzapine Normon may cause symptoms such as drowsiness, dizziness, or vision changes and reduce your reaction ability. These effects, as well as the disease itself, may impair your ability to drive vehicles or operate machines. Therefore, do not drive, operate machines, or engage in other activities that require special attention until your doctor assesses your response to this medication.
Olanzapine Normon contains lactose
This medication contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Follow your doctor's instructions for taking Olanzapine Normon exactly. If you are unsure, consult your doctor or pharmacist again.
Your doctor will tell you how many Olanzapine Normon tablets to take and for how long. The usual daily dose is between 5 and 20 mg. Consult your doctor if your symptoms return, but do not stop taking Olanzapine Normon unless your doctor tells you to.
You should take your Olanzapine Normon tablets once a day, following your doctor's instructions.
Try to take the tablets at the same time every day. You can take them with or without food. Olanzapine Normon tablets are for oral administration. You should swallow the tablets whole with water.
Do not interrupt treatment when you feel better. It is very important that you continue taking it while your doctor tells you to.
If you take more Olanzapine Normon than you should
Consult your doctor, pharmacist, or call the Toxicology Information Service at 91 562 04 20, indicating the medication and the amount used. It is recommended to take the package and package leaflet of the medication to the healthcare professional.
Patients who have taken more Olanzapine Normon than they should have experienced the following symptoms: rapid heartbeat, agitation/aggression, speech problems, unusual movements (especially of the face and tongue), and reduced level of consciousness. Other symptoms may include: acute confusion, seizures (epilepsy), coma, a combination of fever, rapid breathing, sweating, muscle stiffness, drowsiness or lethargy, slowing of respiratory rate, aspiration, increased or decreased blood pressure, and abnormal heart rhythms.
If you forget to take Olanzapine Normon
Take your tablet as soon as you remember. Do not take a double dose to make up for the forgotten dose.
If you stop taking Olanzapine Normon
If you suddenly stop taking Olanzapine Normon, you may experience symptoms such as sweating, insomnia, tremors, anxiety, nausea, or vomiting. Your doctor may suggest gradually reducing the dose before stopping treatment.
Do not interrupt treatment when you feel better. It is very important that you continue taking Olanzapine Normon while your doctor tells you to.
If you have any other questions about using this product, ask your doctor or pharmacist.
Like all medicines, Olanzapine Normon can cause side effects, although not everyone gets them. The side effects observed are classified according to their frequency of occurrence:
Very common(at least 1 in 10 patients):
Weight gain.
Drowsiness.
Increased levels of prolactin (hormone that stimulates milk production in the breast).
Common(at least 1 in 100 patients):
Increased levels of a type of white blood cell (eosinophils).
Increased appetite.
High levels of sugar, high levels of triglycerides.
Agitation, parkinsonism, dyskinesia, unusual movements (especially of the face or tongue).
Decreased blood pressure.
Mild gastrointestinal disorders such as constipation and dry mouth.
Asymptomatic and transient increases in liver enzymes (ALT, AST) especially at the start of treatment.
Fatigue, fluid retention.
Uncommon(at least 1 in 1,000 patients):
High levels of the enzyme creatine phosphokinase.
Sensitivity to sunlight.
Abnormal heart rhythms, such as slowed heartbeat.
Restless legs syndrome.
Excessive salivation.
Rare(at least 1 in 10,000 patients):
Decreased white blood cell count.
Seizures
Skin rashes.
Very rare(less than 1 in 10,000 patients):
Decreased platelet count.
Decreased levels of certain white blood cells (neutrophils).
High levels of sugar and/or initial symptoms of worsening diabetes, with acetone in blood and urine or coma.
Increased triglycerides in blood, decreased body temperature.
Cases of Neuroleptic Malignant Syndrome (NMS) have been reported in association with olanzapine.
Parkinsonism, problems with abnormal repetitive movements such as contortions, jerks, and stiffness.
Sweating, insomnia, tremors, anxiety, nausea, or vomiting when stopping treatment.
Pancreatitis.
Liver disease.
Allergic reaction (e.g., anaphylactoid reaction, angioedema, pruritus, or urticaria).
Rhabdomyolysis (increased concentration of creatine kinase and myoglobinuria).
Difficulty starting urination.
Prolonged and/or painful erection or difficulty urinating.
Frequency not known:
Severe allergic reactions, such as Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), have been reported. DRESS is initially manifested with symptoms similar to those of the flu, with a skin rash on the face that then spreads to other areas, fever, swelling of the lymph nodes, elevated liver enzyme levels in blood tests, and increased levels of a type of white blood cell (eosinophilia).
During treatment with olanzapine, elderly patients with dementia may experience cerebrovascular effects. In this group of patients, very common (at least 1 in 10 patients) problems with walking and falls have been observed. Frequent (at least 1 in 100 patients) pneumonia, urinary incontinence, extreme fatigue, visual hallucinations, increased body temperature, and skin redness have also been observed. Deaths have been reported in this particular group of patients.
Blood clots may form in the veins, especially in the legs (symptoms include swelling, pain, and redness in the leg), and these clots can move through the blood vessels to the lungs, causing chest pain and difficulty breathing. If you experience any of these symptoms, go to your doctor immediately.
If you consider that any of the side effects you are experiencing is serious or if you notice any side effect not mentioned in this package leaflet, inform your doctor or pharmacist.
Keep this medication out of the sight and reach of children.
No special storage conditions are required.
Do not use this medication after the expiration date stated on the package after "EXP". The expiration date is the last day of the month indicated.
Medicines should not be disposed of via wastewater or household waste. Place the packages and medicines you no longer need in the SIGRE collection point at the pharmacy. If you are unsure, ask your pharmacist how to dispose of medicines you no longer need. This will help protect the environment.
Composition of Olanzapine Normon
The active ingredient is: olanzapine 7.5 mg.
The other ingredients are: microcrystalline cellulose (E-460), lactose monohydrate, crospovidone, and magnesium stearate.
Appearance of Olanzapine Normon and contents of the pack
Olanzapine Normon 7.5 mg is presented in the form of cylindrical, biconvex tablets, yellow in color.
Each package contains 56 tablets.
Other presentations:
Olanzapine Normon 2.5 mg EFG tablets
Olanzapine Normon 5 mg EFG tablets
Olanzapine Normon 10 mg EFG tablets
Marketing authorization holder and manufacturer:
Laboratorios Normon, S.A.
Ronda de Valdecarrizo 6,
28760 Tres Cantos, (Madrid)-Spain
Date of the last revision of this package leaflet: March 2020
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
You can access detailed and updated information about this medication by scanning the QR code included in the package leaflet and packaging with your smartphone. You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/68837/P_68837.html.
The average price of OLANZAPINE NORMON 7.5 mg TABLETS in October, 2025 is around 79.33 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for OLANZAPINE NORMON 7.5 mg TABLETS – subject to medical assessment and local rules.